The potential effects of Alzheimer’s disease pathology on M18 levels were further modeled using APP23 transgenic mice, which overexpress a pathogenic variant of the human amyloid precursor protein (APP) [48]. The gene discussed is APP; the disease is early-onset autosomal dominant Alzheimer disease.